Cooperative Agreement NU58DD000040
Award Date 9/30/23
Completion Date 9/29/28
Dollars Obligated $287K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Colorado, USA
Similar Awards
- This $171,488 Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports a nationwide examination of access to comprehensive care in sickle cell disease. The research will be conducted by the University of North Carolina at Chapel Hill's Office of Sponsored Research, with performance scheduled from the award date of September 30, 2025, through August 31, 2026. The project addresses critical gaps in...
- Federal Project Grant Award Summary Emory University received a $797,648 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective June 1, 2026, through February 28, 2031. The research project, titled "RBC-Bound Cell-Free DNA as a Predictor of Acute Anemia in Sickle Cell Disease," will investigate the mechanisms driving acute hemoglobin drops in sickle cell disease (SCD) patients. The...
- Federal Grant Award Summary Award Details: The National Heart, Lung, and Blood Institute (NHLBI) awarded Emory University a Project Grant totaling $646,383 under the Cardiovascular Diseases Research program (CFDA 93.837). The award was obligated on September 15, 2025, with an ultimate completion date of June 30, 2030. Research Scope and Deliverables: This project investigates red blood cell (RBC) transfusion survival and effectiveness in recipients with sickle cell disease (SCD), a clinical...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $175,000 cooperative agreement to Blood Centers of America, Inc. to determine the feasibility of establishing a strategic stockpile of blood donation supplies. This award falls under the Strengthening Emergency Care Delivery in the United States Healthcare System through Health Information and Promotion program (CFDA 93.078), which aims to strengthen emergency care systems and...
- Federal Cooperative Agreement Summary NYU Langone Health's Coordinating Center for CASSIDY (NYU COC) received a $700,000 cooperative agreement award from the Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion, under the Diabetes Prevention and Control Programs (CFDA 93.988). The award, effective September 30, 2025, through September 29, 2029, supports NYU Long Island School of Medicine's role as a coordinating center for diabetes...
- Federal Project Grant Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Drexel University a $503,870 Project Grant effective September 1, 2025 through June 30, 2029 under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct fundamental research on anti-sickling therapies for sickle cell disease. The project aims to develop mechanistic understanding of how fetal hemoglobin (HbF) modulates hemoglobin S (HbS) polymerization and inhibits sickle fiber formation....
- Summary: Puerto Rico Enhanced Surveillance and Control of Endemic and Emerging Arboviruses The Centers for Disease Control and Prevention (CDC), through its National Center for Emerging and Zoonotic Infectious Diseases, awarded Ponce Medical School Foundation Inc. a $1.55 million Cooperative Agreement (CK25-182) effective September 1, 2025, under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084). The five-year award, scheduled for completion August 31,...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $444,125 Project Grant award dated July 24, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, which extends through June 30, 2027, funds a comprehensive research initiative investigating how red cell exchange (RCE) modulates neutrophil function in sickle cell disease (SCD) patients. The...
- Cooperative Agreement Award Summary The District of Columbia Department of Health Care Finance (DHCF) received a Cooperative Agreement award of $4.78M (obligated funds against a requested $7.07M) from the Centers for Medicare and Medicaid Services under the Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885) effective August 1, 2025 through December 31, 2035. The award supports DHCF's implementation of the CGT Access Model, a voluntary federal initiative that facilitates...
- Federal Cooperative Agreement Summary The University of South Carolina received a $498,623 Cooperative Agreement award from the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) under the Diabetes Prevention and Control Programs (CFDA 93.988) beginning September 30, 2025, with a completion date of September 29, 2029. This four-year award supports the optimization and projection of lifestyle behavioral interventions designed to sustain long-term health behaviors and...